Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
LungLife AI
AddedFeb 19, 2024
UpdatedJun 18, 2026
LungLife AI

LungLife AI

Public

LungLife AI: A molecular diagnostics firm using AI for early detection and treatment of lung cancer.

HQ
Thousand Oaks, CA, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

LungLife AI is a molecular diagnostics company dedicated to the early detection and treatment of lung cancer, the deadliest cancer globally. Utilizing machine learning and artificial intelligence, LungLife AI develops clinical diagnostic solutions, including the LungLB® test, which provides critical information through a minimally invasive blood draw to aid clinicians in evaluating indeterminate lung nodules.

LungLife AI has made significant strides in transforming cancer diagnosis and management. Their AI-enabled molecular analysis of cancer biomarkers in blood has the potential to save lives through early diagnosis. The company's innovative approach has garnered attention in the medical community, positioning it as a leader in the field of cancer diagnostics.

LungLife AI - Similar Companies

Breath Diagnostics logo

Breath Diagnostics

Helio Health logo

Helio Health

heliohealth.com

CDx Diagnostics logo

CDx Diagnostics

Biodesix logo

Biodesix

biodesix.com

Hawkeye Bio logo

Hawkeye Bio

hawkeyebio.com

Lucence logo

Lucence

lucence.com

Exai Bio logo

Exai Bio

exai.bio

Delfi Diagnostics logo

Delfi Diagnostics

Precision Health AI logo

Precision Health AI

Freenome logo

Freenome

freenome.com

Onc.AI logo

Onc.AI

onc.ai

Vida Diagnostics logo

Vida Diagnostics

vidalung.ai

Guardant Health logo

Guardant Health

guardanthealth.com

Precipio logo

Precipio

precipiodx.com

Clear Gene logo

Clear Gene

cleargene.com

LungLife AI - Quick Facts

Who are LungLife AI's competitors?

Companies similar to LungLife AI include Breath Diagnostics, Helio Health, CDx Diagnostics and Biodesix.

When was LungLife AI founded?

LungLife AI was founded in 2006.

Where is LungLife AI's headquarters located?

LungLife AI's headquarters is located in Thousand Oaks, CA, US.

How much has LungLife AI raised to-date?

As of Jul 8, 2021, LungLife AI has raised a total of $45.8M (USD).

How many employees does LungLife AI have?

LungLife AI has 11 employees as of Feb 6, 2024.

LungLife AI - Classification

Industry
  • Diagnostics
Ownership
  • Public
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Cancer Diagnostics
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified